Oasis Management Co Ltd. Trims Stake in Astera Labs, Inc. $ALAB

Oasis Management Co Ltd. reduced its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 74.4% during the third quarter, Holdings Channel.com reports. The fund owned 3,000 shares of the company’s stock after selling 8,700 shares during the quarter. Oasis Management Co Ltd.’s holdings in Astera Labs were worth $587,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of ALAB. Assetmark Inc. boosted its position in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the last quarter. Clearstead Trust LLC increased its position in shares of Astera Labs by 46,100.0% in the second quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after purchasing an additional 461 shares during the last quarter. Advisors Asset Management Inc. increased its position in shares of Astera Labs by 68.6% in the second quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after purchasing an additional 194 shares during the last quarter. Manchester Capital Management LLC raised its stake in Astera Labs by 141.5% in the second quarter. Manchester Capital Management LLC now owns 483 shares of the company’s stock valued at $44,000 after purchasing an additional 283 shares in the last quarter. Finally, Pinpoint Asset Management Singapore Pte. Ltd. purchased a new stake in Astera Labs in the third quarter valued at approximately $47,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Loop Capital assumed coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target for the company. Barclays set a $165.00 price objective on shares of Astera Labs in a research report on Thursday, January 15th. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Morgan Stanley reiterated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Citigroup reduced their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, February 11th. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $202.22.

Insider Buying and Selling

In related news, Director Jack R. Lazar sold 7,500 shares of Astera Labs stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $119.80, for a total value of $898,500.00. Following the transaction, the director owned 87,351 shares in the company, valued at $10,464,649.80. This trade represents a 7.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the sale, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at $23,781,796.23. This represents a 5.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 224,292 shares of company stock worth $27,676,069 over the last 90 days. Insiders own 12.50% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB opened at $120.31 on Friday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The stock has a 50 day simple moving average of $147.89 and a two-hundred day simple moving average of $168.18. The firm has a market cap of $20.48 billion, a P/E ratio of 98.61, a P/E/G ratio of 2.36 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business’s revenue was up 91.8% compared to the same quarter last year. During the same period last year, the firm posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.